Dicerna Pharmaceuticals to Present at First Annual Boston Biotech R&D Conference

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology™, today announced that James Jenson, Ph.D., chief executive officer, will present at the 2008 Boston Biotech R&D Conference. The presentation will be held at 3:00 p.m. EST on October 22, 2008 at Harvard Medical School. This conference will bring luminaries from top academic institutions that have been instrumental in establishing the strong Boston biotech community together with executives from several of the area’s most promising emerging biopharmaceutical companies and leaders from the venture capital community and equity markets.